Corticosteroids reliably raise the total white blood cell (WBC) count, and the effect can be surprisingly large. In hospitalized patients given high doses, the average increase peaked at nearly 5 × 10⁹ cells per liter above baseline within two days, and even low doses produced a measurable bump. The rise is driven mainly by neutrophils flooding the bloodstream, while other white cell types actually drop. That split is what makes the picture clinically tricky and worth understanding in detail.
How Corticosteroids Push the Count Up
When you take a corticosteroid like prednisone or dexamethasone, the spike in white cells is not because your body is suddenly manufacturing huge numbers of new immune cells. Most of the increase comes from cells that were already in your body but weren’t being counted. Neutrophils normally stick loosely to the walls of small blood vessels, a state called margination. A single dose of dexamethasone shifts roughly 61% of the rise from that marginated pool into freely circulating blood, where a standard blood draw picks them up. About 29% of the rise comes from neutrophils lasting longer in circulation before being cleared, and only about 10% reflects new cells released from bone marrow.1PubMed. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes
Research using microfluidic models of tiny blood vessels has shed light on how this works at the cellular level. Glucocorticoids reorganize the structural scaffolding inside neutrophils, making them physically softer and less stiff. A softer cell slips through narrow capillaries more easily and detaches more readily from vessel walls. Computational modeling suggests this change in stiffness alone is enough to explain the demargination effect.2PubMed Central. Cellular softening mediates leukocyte demargination and trafficking, thereby increasing clinical blood counts So the headline number on your lab report changes dramatically, but the total number of neutrophils in your body hasn’t increased by nearly as much as it looks.
Not All White Cells Respond the Same Way
A total WBC count is a blended number. Steroids don’t raise every component equally. They push the count in opposite directions depending on the cell type, and understanding this differential is important for anyone interpreting blood work while on these drugs.
Neutrophils climb sharply, as described above. But lymphocytes, the other major category of white cells, drop. Corticosteroids are directly toxic to lymphocytes, triggering programmed cell death through the glucocorticoid receptor. At the same time, they redistribute surviving lymphocytes away from the bloodstream and into the spleen, bone marrow, and lymph nodes. This acute lymphocyte drop can show up within hours of a dose and typically normalizes one to two days after the drug is stopped.3Journal for ImmunoTherapy of Cancer. Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management With chronic use, a sustained decrease in CD4 T cells becomes the most common immune defect, and long-term steroid users can also develop low antibody levels even though their circulating B cell numbers don’t change much in the short term.4ScienceDirect. Steroid-induced secondary immune deficiency
Eosinophils fall too. In asthma patients started on an average oral corticosteroid dose of 35 mg per day, eosinophil counts dropped by roughly 30 to 36 percent within the first month, depending on how high the baseline count was.5PubMed. Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data The mirror image also holds: when patients taper their steroid dose by just 5 mg per day, eosinophil counts bounce back up by about 41 percent.6PubMed Central. Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis This responsiveness is actually one of the reasons eosinophil counts are used to monitor steroid therapy in severe asthma.
The net result on a standard blood panel is a total WBC count that looks high, driven entirely by neutrophils, with lymphocytes and eosinophils suppressed beneath the surface. If you look only at the top-line number, you miss the immunosuppression happening underneath.
How Much the Count Rises Depends on Dose
The magnitude of the WBC spike is dose-dependent, but not in a perfectly linear way. A recent study of non-infected hospitalized patients grouped by steroid dose found that on the second day of treatment, the high-dose group (equivalent to at least 50 mg of prednisone daily) saw a mean increase of about 4.8 × 10⁹ cells per liter. The medium-dose group rose by roughly 1.7 × 10⁹/L, and the low-dose group by only about 0.3 × 10⁹/L.7PubMed Central. Elevation in white blood cell count after corticosteroid use in noninfected hospitalized patients In all groups, the maximum response appeared on day two.
Individual variation is enormous, though. Older research on prednisone found that some patients’ WBC counts blew past 20,000 per cubic millimeter as early as the first day, while others responded more modestly. Even small doses maintained over a long period were capable of producing extreme, persistent leukocytosis.8The American Journal of Medicine. Prednisone-induced leukocytosis: Influence of dosage, method and duration of administration on the degree of leukocytosis Higher doses tended to produce the spike sooner, and most patients hit peak values within about two weeks, after which the count drifted back down but didn’t return all the way to baseline while treatment continued.
Route of administration matters too. Even inhaled corticosteroids at high doses can produce measurable systemic effects on white cells. In one comparison, a high-dose inhaled steroid (1000 micrograms of beclomethasone) raised the neutrophil percentage and lowered lymphocyte counts by a similar amount to 2.5 mg of oral prednisone, a fairly low oral dose.9PubMed. A comparison of the effects of oral prednisone and inhaled beclomethasone dipropionate on circulating leukocytes People using high-dose inhalers might not realize their blood work can be affected, but it can.
Why This Confuses Doctors Looking for Infection
A high white blood cell count is one of the classic signals clinicians use to detect infection. When a patient is already on steroids, that signal becomes unreliable. The steroid pushes the WBC up regardless of whether an infection is present, so a doctor seeing an elevated count has to distinguish between “this is the drug talking” and “this person has a real infection requiring antibiotics.” The differential cell counts help somewhat, since steroid-induced leukocytosis comes overwhelmingly from neutrophils while lymphocytes and eosinophils fall, but bacterial infection also causes neutrophil-dominant elevations.
Band forms, the immature neutrophils that typically signal the bone marrow is ramping up production in response to infection, add another layer of confusion. A case report documented that a patient developed bandemia (elevated band forms) shortly after a single 40 mg dose of dexamethasone with no infection present. While animal studies had shown corticosteroids could trigger bandemia, research specifically examining this phenomenon in humans has been limited.10PubMed Central. Corticosteroids and Bandemia: A Case Report and Review of the Literature Studies in preterm infants receiving dexamethasone have also shown significantly higher band forms along with elevated segmented neutrophils, lower lymphocytes, and lower eosinophils during treatment.11Pediatrics. Early Dexamethasone Therapy and Blood Cell Count in Preterm Infants
The upshot is that traditional infection markers like WBC count and C-reactive protein (CRP) become much less trustworthy in patients taking corticosteroids. In patients with community-acquired pneumonia randomized to prednisone versus placebo, the steroid group had leukocyte counts about 27 percent higher and neutrophil counts about 33 percent higher than the placebo group at all measured time points, while CRP levels dropped by about 46 percent. But procalcitonin levels didn’t differ between the groups.12PubMed Central. Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial That makes procalcitonin a more useful tool for tracking whether an actual infection is resolving in someone on steroids, since it isn’t thrown off the way CRP and white cell counts are.
Neutrophil Numbers Go Up, But Neutrophil Function May Go Down
There is an irony to steroid-induced leukocytosis that is easy to miss. Even though the total number of neutrophils in your bloodstream increases, those neutrophils may not work as well. Laboratory studies have found that hydrocortisone and dexamethasone produce short-term inhibitory effects on the internal killing machinery of neutrophils, the systems responsible for destroying bacteria after a neutrophil engulfs them.13PubMed. Effect of various corticosteroids upon the phagocytic bactericidal activity of neutrophils Steroids also impair the ability of immune cells to migrate to sites of infection or inflammation, partly through effects on adhesion molecules that help cells stick to vessel walls and crawl toward trouble.3Journal for ImmunoTherapy of Cancer. Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management
So a patient on corticosteroids can simultaneously have lab values that look reassuring on paper (plenty of white cells, low CRP) and an immune system that is genuinely weakened. The high neutrophil count is somewhat cosmetic: you have more of them flowing through your blood, but they are less able to get where they are needed and less efficient at killing once they arrive. Combined with the lymphocyte depletion described earlier, this is why chronic steroid use is a well-known risk factor for opportunistic infections.
What Cushing’s Disease Tells Us
Cushing’s disease, in which the body chronically overproduces cortisol, offers a natural experiment in what sustained excess cortisol does to blood counts. A study of 28 patients with Cushing’s disease found that about 40 percent had elevated WBC counts before treatment, with a mean count of roughly 10,500 cells per microliter. After successful treatment to bring cortisol levels down, the mean WBC count fell to about 8,400 and the mean neutrophil count dropped from about 7,600 to 5,300. Lymphocyte counts moved in the opposite direction, rising from about 2,000 to 2,300. Critically, even patients whose baseline WBC was technically within normal range still saw a significant drop after treatment, suggesting the cortisol excess was inflating their counts into the upper-normal zone.14PubMed. Elevated white blood cell counts in Cushing’s disease: association with hypercortisolism
Beyond simple cell counts, Cushing’s patients show changes in immune cell activation markers and higher levels of certain pro-inflammatory monocyte and neutrophil subsets that may contribute to the elevated cardiovascular risk associated with the disease.15PubMed Central. Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? This reinforces the idea that the WBC changes caused by glucocorticoids are not just a lab curiosity. In a setting of chronic excess, they may actively contribute to disease.
Time of Day and the Body’s Own Cortisol Rhythm
Your body’s natural cortisol levels follow a circadian pattern, peaking in the early morning and dropping in the evening. This rhythm affects baseline white cell behavior in ways that interact with any exogenous steroids you take. Animal research has shown that during the evening, when cortisol is naturally low, there is significantly more adhesion of white cells to blood vessel walls and a more robust response to inflammatory signals. In the morning, when cortisol is higher, circulating neutrophil counts are elevated and vessel-wall adhesion is lower. Supplementing with exogenous glucocorticoids for two weeks abolished these circadian rhythms entirely, flattening the daily fluctuation in both circulating neutrophil counts and the early inflammatory response.16PubMed. Effects of the circadian rhythm of corticosteroids on leukocyte-endothelium interactions in the AM and PM
For practical purposes, this means the timing of a blood draw relative to your steroid dose and your body’s natural cortisol cycle can influence what the lab report shows. A morning blood draw on someone who took their steroid dose first thing will look different from an afternoon draw on the same person. If you’re trying to track trends over time, consistency in when samples are taken helps avoid misleading comparisons.
Exercise, Steroids, and White Cell Counts
Exercise independently causes a temporary spike in white cells, particularly lymphocytes. When corticosteroids are on board, they modify this exercise response in specific ways. In one study, subjects who ran on a treadmill normally developed a lymphocyte surge led by B cells. When the same exercise was repeated five hours after taking 60 mg of prednisone, the lymphocyte rise was suppressed in both T and B cells. With a shorter two-hour gap after the dose, only T cell lymphocytosis was blocked, while B cells still responded.17PubMed Central. Effect of corticosteroids on exercise-induced lymphocytosis Separate work confirmed that prednisone taken two hours before exercise caused the expected granulocytosis and lymphocyte drop, with a particularly strong suppressive effect on B cells and monocytes during the exercise-induced rise.18PubMed. Alterations of beta-adrenoceptors on human leukocyte subsets induced by dynamic exercise: effect of prednisone
For anyone on steroids who exercises regularly and has periodic blood work, these interactions are worth being aware of. A blood draw taken shortly after a workout while on prednisone will reflect both effects layered on top of each other, potentially making the results harder to interpret.
Anabolic Steroids Are a Different Story
When people ask “do steroids affect white blood cell count,” they sometimes mean anabolic androgenic steroids, the kind used for bodybuilding and performance enhancement. These are chemically and pharmacologically distinct from corticosteroids, and their effects on white cells differ. A review of the literature found that anabolic steroids with an intact steroid nucleus tend to be immunosuppressive, reducing immune cell numbers and function. They can adversely influence lymphocyte growth and division, antibody production, and the activity of natural killer cells. Variants with structural alterations to the nucleus showed the opposite pattern, stimulating T cell proliferation.19Open Life Sciences. Anabolic androgenic steroids effects on the immune system: a review
In terms of raw cell counts, a study comparing current and former anabolic steroid users with non-users found that active users had white cell counts roughly 33 percent higher than controls, along with elevated hemoglobin and platelets.20PubMed. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers So anabolic steroids can raise white cell counts too, but through different pathways and with different downstream immune consequences than corticosteroids.
Chronic Steroid Use and Platelet-to-White-Cell Ratios
Because corticosteroids reliably inflate white cell counts without proportionally changing platelet numbers, the ratio of platelets to white cells drops in chronic steroid users. In a study of patients undergoing brain tumor surgery, chronic steroid users had a significantly lower platelet-to-WBC ratio compared to non-users. This ratio was also independently associated with the risk of pulmonary embolism after surgery.21PLoS One. Association between preoperative chronic steroid use and pulmonary embolism in adult tumor craniotomy: Linking role of platelet-to-white blood cell ratio This kind of derived ratio is gaining attention as a marker that may capture steroid-related risk in ways that raw cell counts alone miss, though it remains an area of active investigation rather than established clinical practice.